Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?

Endocrine Journal

Volumn 54, Issue 5, 2007, Pages 695-702

  Yasuda, Tetsuyuki ^a   Matsuhisa, Munehide ^a   Fujiki, Noritaka ^b   Sakamoto, Fumie ^b   Tsuji, Mayumi ^b   Fujisawa, Noriko ^b   Kimura, Masato ^b   Ishibashi, Rieko ^b   Kaneto, Hideaki ^a   Yamasaki, Yoshimitsu ^a   Watarai, Takao ^c   Imano, Eiichi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^c KOSHIEN UNIVERSITY   (Japan)

Author keywords

Carotid atherosclerosis; Central obesity; Diabetes; Metabolic syndrome

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; ECHOTOMOGRAPHY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; ECHOGRAPHY; EVALUATION; HISTOLOGY; INTIMA; JAPAN; MIDDLE AGED; OBESITY; PATHOLOGY; PREVALENCE; PROGNOSIS; WAIST HIP RATIO;

AGED; CAROTID ARTERIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PROGNOSIS; RISK FACTORS; TUNICA INTIMA; WAIST-HIP RATIO;

EID: 40449142348     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-210     Document Type: Article

References (32)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
3. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164: 1066-1076.
4. Alberti K, Zimmet P (1998) Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: Report of a WHO consultation. Diabetic Med 15: 539-553.
5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA 285: 2486-2497.
6. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28: 364-376.
7. Einhorm D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9: 237-252.
8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Flanklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112: 2735-2752.
9. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome: a new world wide definition. Lancet 366: 1059-1062.
10. Matsuzawa Y (2005) Metabolic syndrome-definition and diagnostic criteria in Japan. J JPN Soc Int Med 94: 188-203.
11. Carr B, Utzschneider K, Hull R, Kodama K, Retzlaff B, Brunzell J, Shofer J, Fish B, Knopp R, Kahn S (2004) Intra-abdominal fat is a major risk determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 2087-2094.
12. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469-480.
13. Fujimoto W, Bergstrom R, Boyko E, Chen K, Leonetti D, Newell-Morris L, Shofer J, Wahl P (1999) Visceral adiposity and incident coronary heart disease in Japanese-American men: 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22: 1808-1812.
14. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J (1986) Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123: 504-516.
15. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444.
16. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L (2001) The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44: 1148-1154.
17. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M (2004) The metabolic syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 21: 52-58.
18. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P (2004) Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27: 2689-2694.
19. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer W, Price TR, Gardin JM, Savage PJ (1992) Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 23: 1752-1760.
20. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP (1998) The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128: 262-269.
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22.
22. Salonen R, Salonen JT (1991) Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 229: 225-231.
23. Su TC, Jeng JS, Chien KL, Sung FC, Hsu HC, Lee YT (2001) Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke 32: 2265-2271.
24. Mita T, Watada H, Uchino H, Shimizu T, Hirose T, Tanaka Y, Kawamori R (2006) Association of Creactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus. Endocrine J 53: 45-50.
25. Saely C, Koch L, Schmid F, Marte T, Aczel S, Langer P, Hoefle G, Drexel H (2006) Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29: 901-907.
26. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 12: 295-300.
27. Matsuzawa Y (1997) Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13: 3-13.
28. Ahima RS, Jeffery SF (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11: 327-332.
29. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
30. Lemieux I, Pascot A, Couillard C, Lamarche B, Techernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres J-P (2000) Hypertriglycemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102: 179-184.
31. Costa L, Canani L, Lisboa H, Tres G, Gross J (2004) Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 21: 252-255.
32. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H, Saito Y, Ohashi Y, Akanuma Y, Yamada N (2006) The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions. Diabetes Care 29: 145-147.